Overall, these studies highlighted that inducing necroptosis through the delivery of MLKL mRNA or protein can enhance anti-tumor immunity, emphasizing its potential as a treatment to trigger immunogenic tumor cell death and consequent activation of anti-tumor immune reaction. This evidence concerns the gene MLKL and neoplasm.